small molecule

BUSPIRONE HYDROCHLORIDE

BUSPIRONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameBUSPIRONE HYDROCHLORIDE
Active ingredientBUSPIRONE HYDROCHLORIDE
Strength7.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.